Litcius/Paper detail

BTK inhibitors as potential therapies for multiple sclerosis

Jorge Correale

2021The Lancet Neurology29 citationsDOI

Topics & Concepts

Multiple sclerosisBruton's tyrosine kinaseTyrosine kinaseKinaseCancer researchPhosphorylationSignal transductionMedicineReceptor tyrosine kinaseApoptosisImmunologyBiologyCell biologyBiochemistryChronic Lymphocytic Leukemia ResearchProtein Tyrosine PhosphatasesCancer Mechanisms and Therapy
BTK inhibitors as potential therapies for multiple sclerosis | Litcius